Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D
================================================================================================================================================================================================

* Junsik Park
* Jung Bok Lee
* Myong Cheol Lim
* Byoung-Gie Kim
* Jae-Weon Kim
* Sunghoon Kim
* Chel Hun Choi
* Hee Seung Kim
* Sang Yoon Park
* Jung-Yun Lee